Literature DB >> 8384849

Release of the p53-induced repression on thymidine kinase promoter by single p53-binding sequence.

J N Yuan1, B H Liu, H Lee, Y T Shaw, S T Chiou, W C Chang, M D Lai.   

Abstract

Herpes simplex thymidine kinase (TK) promoter was shown to be repressed by the wild-type p53. Using a model system that the p53-binding site was linked to the thymidine kinase promoter, we demonstrated that single p53-specific binding site was sufficient to abolish the repression. On the contrary, the mutant p53 had the opposite effects on the HSV-TK promoter in BHK cells. The results suggest that the p53-binding site may act as an enhancer to regulate the gene expression in a novel way in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384849     DOI: 10.1006/bbrc.1993.1268

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  p53 and the CNS: tumors and developmental abnormalities.

Authors:  G Fulci; E G Van Meir
Journal:  Mol Neurobiol       Date:  1999-02       Impact factor: 5.590

2.  PMA induces expression from the herpes simplex virus thymidine kinase promoter via the activation of JNK and ERK in the presence of adenoviral E1A proteins.

Authors:  Amde Selassie Shifera; John A Hardin
Journal:  Arch Biochem Biophys       Date:  2009-08-23       Impact factor: 4.013

3.  Identification of two novel functional p53 responsive elements in the herpes simplex virus-1 genome.

Authors:  Jui-Cheng Hsieh; Ryan Kuta; Courtney R Armour; Paul E Boehmer
Journal:  Virology       Date:  2014-05-29       Impact factor: 3.616

4.  p53-dependent activation of the mouse MCK gene promoter: identification of a novel p53-responsive sequence and evidence for cooperation between distinct p53 binding sites.

Authors:  P Jackson; M Shield; J Buskin; S Hawkes; M Reed; K Perrem; S D Hauschka; A Braithwaite
Journal:  Gene Expr       Date:  1995

5.  Influence of p53 on herpes simplex virus type 1 vectors for cancer gene therapy.

Authors:  S S Yoon; N M Carroll; E A Chiocca; K K Tanabe
Journal:  J Gastrointest Surg       Date:  1999 Jan-Feb       Impact factor: 3.267

6.  Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1.

Authors:  D J O'Connor; E W Lam; S Griffin; S Zhong; L C Leighton; S A Burbidge; X Lu
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.